Hamel Associates’s iShares iBonds Dec 2032 Term Corporate ETF IBDX Stock Holding History
Bought
Maintained
Sold
Other funds holding IBDX
ACA
CIA
CAI
SIC
KA
Hamel Associates's IBDX Position: Q2 2026 in Review
Hamel Associates increased its iShares iBonds Dec 2032 Term Corporate ETF (IBDX) stake by 48% in Q2 2026, buying an estimated $262K and bringing the position to 32,285 shares worth $813K. The position accounts for 0.22% of the portfolio, ranked #60.
Hamel Associates first reported a position in IBDX in Q1 2026 and has held it in 2 quarters since. 228 funds tracked by Wall St. Rank hold IBDX as of Q2 2026.
- Hamel Associates held 32,285 shares of iShares iBonds Dec 2032 Term Corporate ETF worth $813K as of Q2 2026.
- Hamel Associates bought 10,405 iShares iBonds Dec 2032 Term Corporate ETF shares in Q2 2026, an estimated $262K.
- iShares iBonds Dec 2032 Term Corporate ETF made up 0.22% of Hamel Associates's portfolio in Q2 2026, its #60 holding.
- Hamel Associates first reported a position in iShares iBonds Dec 2032 Term Corporate ETF in Q1 2026 and has held it in 2 quarters since.
- 228 funds tracked by Wall St. Rank held iShares iBonds Dec 2032 Term Corporate ETF as of Q2 2026.
Based on Hamel Associates's 13F filing for Q2 2026, filed 27 Jul 2026.